Supernus Pharmaceuticals Inc

SUPN

$30.36

+3.4% last 12 months

Market Cap

$1.54 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$23.15 - $34.50

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

18.88x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $1.54 Billion
Enterprise Value $1.47 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +3.4%
52-Week High $34.50
52-Week Low $23.15
Beta 0.9
Outstanding Shares 52.9 Million
Avg 30 Day Volume 385 Thousand

Valuation

P/E Ratio 18.88
PEG -40.97
Earnings per Share $1.51
Price to Sales Ratio 3.04
Price to Book Ratio 2.02
Revenue to Enterprise Value 2.61
EBIT to Enterprise Value 12.58
Total Debt to Enterprise Value 0.25
Debt to Equity 0.46

Profitability

Revenue $564 Million
Gross Profit $488 Million
EBIT $117 Million
Net Income $81.8 Million
Profit Margin 14.49%
Quarterly Earnings Growth (YoY) -46.1%
Return on Equity 10.09%
Return on Assets 5.26%
Return on Invested Capital 8.87%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Supernus Pharmaceuticals Inc

CEO: Jack Khattar

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Zogenix Inc
Zogenix Inc
United Therapeutics Corp
United Therapeutics Corp
Lilly(Eli) & Co
Lilly(Eli) & Co
Abbott Laboratories
Abbott Laboratories
Johnson & Johnson
Johnson & Johnson

News